Trademark: 97978677
Word
AVERITAS PHARMA
Status
Pending
Status Code
819
Status Date
Wednesday, August 28, 2024
Serial Number
97978677
Mark Type
4
Filing Date
Tuesday, April 26, 2022
Published for Opposition
Tuesday, March 28, 2023

Trademark Owner History
Averitas Pharma, Inc. - Owner At Publication

Classifications
5 Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, and neurological diseases and disorders
"PHARMA"

Trademark Events
Apr 29, 2022
New Application Entered
May 2, 2022
New Application Office Supplied Data Entered
Feb 21, 2023
Examiners Amendment -Written
Feb 21, 2023
Examiners Amendment E-Mailed
Feb 14, 2023
Assigned To Examiner
Feb 21, 2023
Examiner's Amendment Entered
Feb 21, 2023
Approved For Pub - Principal Register
Mar 8, 2023
Notification Of Notice Of Publication E-Mailed
Mar 28, 2023
Published For Opposition
Mar 28, 2023
Official Gazette Publication Confirmation E-Mailed
May 23, 2023
Noa E-Mailed - Sou Required From Applicant
Nov 20, 2023
Sou Extension 1 Filed
Nov 20, 2023
Sou Teas Extension Received
Nov 22, 2023
Notice Of Approval Of Extension Request E-Mailed
May 2, 2024
Divisional Request Received
May 2, 2024
Sou Extension 2 Granted
May 2, 2024
Sou Extension 2 Filed
May 2, 2024
Sou Teas Extension Received
May 2, 2024
Teas Statement Of Use Received
May 3, 2024
Notice Of Approval Of Extension Request E-Mailed
Jun 10, 2024
Case Assigned To Intent To Use Paralegal
Jun 11, 2024
Itu Office Action Issued For Divisional Request
Aug 7, 2024
Response To Itu Office Action Entered
Feb 21, 2023
Notification Of Examiners Amendment E-Mailed
Nov 20, 2023
Sou Extension 1 Granted
May 2, 2024
Use Amendment Filed
May 2, 2024
Teas Request To Divide Received
Aug 7, 2024
Teas Response To Office Action Received
Aug 7, 2024
Itu Office Action Issued For Divisional Request
Aug 13, 2024
Divisional Processing Complete
Aug 13, 2024
Statement Of Use Processing Complete
Aug 28, 2024
Allowed Principal Register - Sou Accepted
Aug 28, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed

Trademark Alertz updated from USPTO on 2030-01-24